The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension.

MLA

Simpson, Catherine E., et al. “The Angiostatic Peptide Endostatin Enhances Mortality Risk Prediction in Pulmonary Arterial Hypertension.” ERJ Open Research, vol. 7, no. 4, Oct. 2021. EBSCOhost, https://doi.org/10.1183/23120541.00378-2021.

APA

Simpson, C. E., Griffiths, M., Yang, J., Nies, M. K., Vaidya, R. D., Brandal, S., Martin, L. J., Pauciulo, M. W., Lutz, K. A., Coleman, A. W., Austin, E. D., Ivy, D. D., Nichols, W. C., Everett, A. D., Hassoun, P. M., & Damico, R. L. (2021). The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension. ERJ Open Research, 7(4). https://doi.org/10.1183/23120541.00378-2021

Chicago

Simpson, Catherine E, Megan Griffiths, Jun Yang, Melanie K Nies, R Dhananjay Vaidya, Stephanie Brandal, Lisa J Martin, et al. 2021. “The Angiostatic Peptide Endostatin Enhances Mortality Risk Prediction in Pulmonary Arterial Hypertension.” ERJ Open Research 7 (4). doi:10.1183/23120541.00378-2021.